Positive Progress in ImmunoPET—Not Just a Coincidence-Reference-Cited by-同舟云学术

Positive Progress in ImmunoPET—Not Just a Coincidence

Published:2010-06 Issue:3 Volume:25 Page:253-261
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

McCabe Katelyn E.¹,Wu Anna M.¹

Affiliation:

1. David Geffen School of Medicine at UCLA, Los Angeles, California.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2010.0776

Reference40 articles.

1. Molecular Imaging of Cancer with Copper-64 Radiopharmaceuticals and Positron Emission Tomography (PET)

2. Radioimmunoimaging with Longer-Lived Positron-Emitting Radionuclides: Potentials and Challenges

3. Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-In-Human Pilot PET Immunoimaging Study of ⁶⁴Cu-Anti-Carcinoembryonic Antigen Monoclonal Antibody (hT84.66-M5A) in Patients with Carcinoembryonic Antigen-Producing Cancers;Cancer Biotherapy and Radiopharmaceuticals;2023-02-01

2. ImmunoPET Directed to the Brain: A New Tool for Preclinical and Clinical Neuroscience;Biomolecules;2023-01-13

3. Diagnosis of Pancreatic Ductal Adenocarcinoma by Immuno-Positron Emission Tomography;Journal of Clinical Medicine;2021-03-10

4. Perspectives on metals-based radioimmunotherapy (RIT): moving forward;Theranostics;2021

5. Copper-64-immunoPET imaging: bench to bedside;The Quarterly Journal of Nuclear Medicine and Molecular Imaging;2020-12